title: [The use of copper sulfate in the treatment of esophageal cancer].
abstract: The authors have developed and approbated a methodology involving the use of copper sulphate as a radio sensitizer. The methods permit the enhancement of the immediate efficiency of treatment up to the level comparative with the best results of radiosensibilization at the expense of cytostatic agents. The incidence of complete regression of the tumor came up to 43.3%, partial one to 53.3%, stabilization to 3.3%. The advantages of the use of copper sulphate include low toxicity, practical availability, and exceptional cheapness, which facts suggest superiority of the proposed methods to other methodologies.
authors.forename: S I
authors.initials: SI
authors.lastname: Kirkilevskiĭ
authors.forename: V L
authors.initials: VL
authors.lastname: Ganul
authors.forename: S L
authors.initials: SL
authors.lastname: Zaĭtsev
authors.forename: L T
authors.initials: LT
authors.lastname: Khrulenko
authors.forename: P S
authors.initials: PS
authors.lastname: Krakhmalev
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D019327:Copper Sulfate / Q000009:adverse effects / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D011838:Radiation-Sensitizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D011838:Radiation-Sensitizing Agents; D019327:Copper Sulfate